Concepedia

Sven Nylander

SN

41

Publications

2.6K

Citations

26

H-Index

1994

Active since

Affiliations

AstraZeneca (Sweden)(Current)

The University of Texas Medical Branch at Galveston

Baylor College of Medicine

AstraZeneca (United Kingdom)

Linköping University Hospital

Sven Nylander is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and vascular biology.

ORCID

Top concepts

Publications per year

1994–2022

41

Publications

41

Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the Rat

A.‐L. Ungell, Sven Nylander, Sara Bergstrand et al. · Journal of Pharmaceutical Sciences · 1998 · 254 citations

Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1

Duncan Armstrong, Claire Summers, Lorna Ewart et al. · Journal of Cardiovascular Pharmacology and Therapeutics · 2014 · 238 citations

Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans

Ann Wittfeldt, Håkan Emanuelsson, Gunnar Brandrup‐Wognsen et al. · Journal of the American College of Cardiology · 2013 · 194 citations

, , +8

Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans

Hans Lennernäs, Sven Nylander, A.‐L. Ungell · Pharmaceutical Research · 1997 · 168 citations

Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism

Sven Nylander, Eti Alessandra Femia, Mariangela Scavone et al. · Journal of Thrombosis and Haemostasis · 2013 · 148 citations · Full text

, , +11

Rows per page

1–5 of 41